Trademark: 79294389
Word
OLINK
Status
Registered
Status Code
700
Status Date
Tuesday, September 21, 2021
Serial Number
79294389
Registration Number
6488596
Registration Date
Tuesday, September 21, 2021
Mark Type
3000
Filing Date
Wednesday, February 12, 2020
Published for Opposition
Tuesday, July 6, 2021

Trademark Owner History
Olink Proteomics AB - Original Registrant

Classifications
9 Apparatus and instruments for scientific use, namely, real-time PCR instruments for measuring of proteins and other molecules and sample preparation instruments; apparatus and instruments for diagnostic use, namely, real-time PCR instruments for measuring of proteins and other molecules and sample preparation instruments for research use other than for medical use; scientific apparatus and instruments used in the measuring of molecules, molecular proteins and peptides other than for medical use; diagnostic apparatus and instruments used in scientific analysis, namely, diagnostic apparatus and instruments for the measurement of molecules and instruments for measuring proteins for non-medical purposes; downloadable software for measuring of molecules in the nature of molecule sequencing and data analysis; laboratory equipment and supplies for scientific research use and drug development, namely, primer PCR plates, containers and ampoules filled with incubation solutions, probe liquids being biochemical reagents, dilution and detection solutions as well as control liquids for use in testing and analyzing tissue and biological sample for non-medical purposes
5 Chemical preparations for biological sample analysis for medical diagnostic purposes
1 Chemicals used in scientific analysis and research and for industrial use; chemicals for detection of molecules including molecular proteins and peptides; chemical kits for analysing biological sample materials for scientific purposes comprising sample dilution, antibodies, enzymes, detection solutions, polymerase; incubation stabilizers in the nature of diagnostic preparations and chemical preparations serving as positive control chemicals reagents for research use and use in drug development
42 Laboratory research regarding detection of molecules, molecular proteins and peptides; pharmaceutical drug development services; diagnostic development, namely, custom design and development of chemical reagents and biochemical assays; data science and biostatistics services, namely, data analysis relating to protein biomarker analysis for scientific research purposes; laboratory biomarker analysis services and related data analysis
The mark consists of the wording "OLINK" to the right of a circular design formed by three ovals.

Trademark Events
Mar 31, 2024
Change Of Name/Address Rec'd From Ib
Oct 28, 2022
New Representative At Ib Received
Mar 21, 2022
Final Decision Transaction Processed By Ib
Mar 2, 2022
Final Disposition Notice Sent To Ib
Mar 2, 2022
Final Disposition Processed
Dec 21, 2021
Final Disposition Notice Created, To Be Sent To Ib
Sep 21, 2021
Registered-Principal Register
Jul 19, 2021
Notification Processed By Ib
Jul 6, 2021
Official Gazette Publication Confirmation E-Mailed
Jul 6, 2021
Published For Opposition
Jun 30, 2021
Notification Of Possible Opposition Sent To Ib
Jun 30, 2021
Notice Of Start Of Opposition Period Created, To Be Sent To Ib
Jun 16, 2021
Notification Of Notice Of Publication E-Mailed
May 25, 2021
Withdrawn From Pub - Og Review Query
May 7, 2021
Approved For Pub - Principal Register
Apr 17, 2021
Teas/Email Correspondence Entered
Apr 16, 2021
Correspondence Received In Law Office
Apr 16, 2021
Teas Response To Office Action Received
Nov 9, 2020
Refusal Processed By Ib
Oct 22, 2020
Non-Final Action Mailed - Refusal Sent To Ib
Oct 22, 2020
Refusal Processed By Mpu
Oct 3, 2020
Application Filing Receipt Mailed
Oct 1, 2020
Non-Final Action (Ib Refusal) Prepared For Review
Sep 30, 2020
Non-Final Action Written
Sep 29, 2020
Assigned To Examiner
Sep 29, 2020
New Application Office Supplied Data Entered
Sep 24, 2020
Sn Assigned For Sect 66a Appl From Ib

Trademark Alertz updated from USPTO on 2030-01-24